Grand River Aseptic Manufacturing’s Strategic Partnerships with Drug Delivery Leaders

Grand River Aseptic Manufacturing and leaders in advanced drug delivery devices are evolving their relationships to serve pharma and biotech into the future.

The market is rapidly evolving towards patient-centric drug delivery innovations, particularly for the subcutaneous (subQ) administration of concentrated monoclonal antibodies (mAbs). There is a growing emphasis on patient comfort and convenience in drug administration. Subcutaneous delivery methods enable patients to self-administer treatments at home, reducing the need for frequent clinic visits, which is especially important for managing chronic conditions that require regular dosing. Technological advancements in delivery devices now allow for the concentration of mAbs without compromising their efficacy or safety. Pre-filled syringes, autoinjectors, and wearable devices can significantly enhance the user’s experience. Strengthening the relationships between drug delivery device companies and Contract Development and Manufacturing Organizations (CDMOs) will help break down barriers and improve the customer’s experience.

Grand River Aseptic Manufacturing (GRAM) and our drug delivery partners have increased our collaboration to stay at the forefront of client value delivery and fill-finish services for emerging technologies. Our partnerships provide unique value beyond conventional CDMO services by accelerating filling and finishing solutions of syringes and cartridges for our partner’s innovative autoinjectors and on-body delivery systems.

These partnerships break down a barrier in the drug delivery ecosystem by combining our expertise ahead of time. Strong relationships form the foundation of these partnerships, which gives us specialized knowledge in understanding client solutions for autoinjector and on-body delivery designs as they evolve. Together, we provide a comprehensive solution for developing and manufacturing devices to deliver biologics and put patient care first.

LTS and Grand River Aseptic Manufacturing form strategic alliance for sterile fill-finish of Sorrel™ wearable injector containers

  • On-body devices provide an essential solution in patient care. LTS’ Sorrel is the next-generation wearable device for large-volume drug products designed for patient convenience. As you decide on your device, an important question arises: Where might the cartridge be filled? GRAM provides a solution to that question. We have the unique experience of filling large-volume cartridges today.
  • Our partnership supports the client’s journey with an end-to-end solution for pre-loaded and pre-filled containers. Product development and commercialization are streamlined, allowing for faster market access and production. GRAM’s expertise in aseptic manufacturing capabilities for biologics and varying equipment capacity support scalable solutions.

LTS Sorrel and GRAM Partnership

SHL Medical and Grand River Aseptic Manufacturing forge strategic partnership to offer fill finish services for RTU cartridge used in Maggie 5.0® autoinjector

  • Pharmaceutical organizations now benefit from an established supply chain and faster market entry for the Maggie® 5.0 autoinjector. Maggie® was developed to open new pathways for handheld devices to accommodate a wider variety of formulation characteristics that were not possible with prefilled syringe-based autoinjectors.
  • By combining SHL’s expertise in developing innovative drug delivery solutions and GRAM’s expertise in filling and finishing for diverse client needs, we are creating a streamlined solution that will offer significant value to pharmaceutical companies and, ultimately, patients. Our collaboration introduces GRAM’s services for filling the cartridge used in the Maggie® 5.0 mL.

SHL Maggie and GRAM Partnership

The dedication to developing innovative drug delivery devices to improve patient care aligns seamlessly with our patient-centered culture and commitment to the success of our customer’s impactful therapeutics. We welcome discussions regarding our partnerships and how best to support your product.

Start The Conversation